Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biomarkers
biomarkers
FDA grants first qualification of a clinical safety biomarker
BioCentury
Fri, 10/26/18 - 08:36 pm
FDA
biomarkers
acute kidney injury
[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®
CP Wire
Tue, 10/9/18 - 11:58 am
Firalis
Celemics
genomics
biomarkers
IncRNAs
FiMICS
[release] Firalis and Celemics announce an agreement for the commercialization of a unique proprietary long non- coding RNA (lncRNA) panel, FiMICS®
Wed, 10/10/18 - 10:12 am
Firalis
Celemics
genomics
biomarkers
IncRNAs
FiMICS
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Forbes
Tue, 07/31/18 - 10:21 am
depression
biomarkers
diagnostics
Nano Vision
Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs
Fierce Biotech
Wed, 06/6/18 - 10:30 am
Genentech
Microbiotica
microbiome
IBD
biomarkers
ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?
Fierce Pharma
Mon, 06/4/18 - 10:24 pm
Bristol-Myers Squibb
biomarkers
ASCO 2018
Opdivo
Preliminary Study Finds Potential Biomarker of Subconcussive Head Trauma
CP Wire
Tue, 05/29/18 - 09:06 pm
biomarkers
concussions
head trauma
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
CP Wire
Wed, 05/23/18 - 10:30 pm
pancreatic cancer
diagnostics
biomarkers
CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Inflammatory Bowel Disease
CP Wire
Mon, 04/16/18 - 04:18 pm
CytoReason
IBD
inflammatory bowel disease
biomarkers
After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field
Endpoints
Tue, 04/10/18 - 11:19 am
FDA
Alzheimer's disease
R&D
NIH
biomarkers
First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)
CP Wire
Wed, 04/4/18 - 09:53 am
biomarkers
enzastaurin
Denovo Therapeutics
DLBCL
R-CHOP
This biotech aims to transform the diagnosis of mental illness. Michael Phelps backs it. Can it really work?
Stat
Fri, 07/21/17 - 03:14 pm
mental illness
biotech
Michael Phelps
diagnostics
Medibio
biomarkers
FDA approves diagnostic that simultaneously screens for multiple cancer biomarkers
Drug Delivery Business News
Sat, 06/24/17 - 09:07 am
FDA
Thermofisher
diagnostics
biomarkers
non-small cell lung cancer
Oncomine Dx Target Test
An Unprecedented FDA Approval Bodes Well for this Drug Stock
Motley Fool
Wed, 06/7/17 - 10:05 am
Merck
FDA
Keytruda
biomarkers
solid tumors
Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval
Endpoints
Sat, 06/3/17 - 09:21 am
Loxo Oncology
ASCO 2017
biomarkers
LOXO-101
larotrectinib
Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker
Endpoints
Wed, 05/24/17 - 10:59 am
Merck
Keytruda
FDA
biomarkers
cancer
5 trends being impacted by biomarkers
BioPharma Dive
Tue, 02/14/17 - 07:39 pm
biomarkers
precision medicine
combo trials
diagnostics
R&D
cancer
liquid biopsy
Astellas inks biomarker deal to pinpoint Xtandi patients
BioPharma Dive
Sat, 02/4/17 - 09:59 am
Astellas
Xtandi
biomarkers
patients
tumor profiles
PDUFA 6 procedures will include patients, biomarkers for 2018-2022
BioPharma Dive
Mon, 07/18/16 - 11:04 am
FDA
PDUFA
patients
biomarkers
Arno Therapeutics to Present Data Validating Target Biomarker at European Cancer Congress 2013
Yahoo/Globe Newswire
Sat, 09/28/13 - 12:10 pm
onapristone
breast cancer
biomarkers
Arno Therapeutics
Pages
« first
‹ previous
1
2
3
4
next ›
last »